Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.

Hepato-gastroenterology - 1 Jan 2000

Kunisaki Chikara, Imada Toshio, Yamada Roppei, Hatori Shinsuke, Kinbara Kazuhiro, Watai Kiichi, Akiyama Hirotoshi, Nomura Masato, Matsuda Goro, Otsuka Yuichi, Ono Hidetaka, Shimada Hiroshi

Abstract excerpt

BACKGROUND/AIMS: It is important to clarify the predictive and prognostic factors for chemoradiotherapy (CRT) in patients with inoperable esophageal cancer. METHODOLOGY: Forty-one patients with inoperable advanced esophageal cancer were evaluated. The predictive factors for the response to CRT (low-dose 5-FU and Cisplatin (FP) therapy plus 60 Gy of radiation) and the prognostic factors after CRT were analyzed....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cisplatin

Share to Combined Modality Therapy

Share to Esophageal Neoplasms

Share to Fluorouracil

Share to Keratin-19

Share to Keratins

Source

Identifiers

PMID: 16795974

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.PMID 16795974Read ↗

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.Semantic proximity Read ↗

Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy.Semantic proximity Read ↗

Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols.Semantic proximity Read ↗

Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.Semantic proximity Read ↗

Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.Semantic proximity Read ↗

Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.Semantic proximity Read ↗

Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.Semantic proximity Read ↗

[Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].Semantic proximity Read ↗

Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.